STAT2d
Sickle cell community scrambles to find safe plan after a drug is pulled from the market
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
The Gazette2d
Why gene therapy for sickle cell is slow to catch on with patients
LOS ANGELES (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with ...
A daily battle: Kamarie Crawford faces on-going fight with Sickle Cell
September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...
devdiscourse1d
The Struggles and Hopes of Sickle Cell Patients Eyeing Costly Gene Therapies
Zoe Davis, a 20-year-old student, continues to battle severe sickle cell pain while hoping for relief from new gene therapies ...
Pfizer to Withdraw Sickle-Cell Drug Oxbryta From Worldwide Markets
The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the ...
Medpage Today on MSN3d
Sickle Cell Disease Drug Pulled From Global Markets
Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an ...
Revolutionary sickle cell treatment providing hope and equity in action
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...
West Virginia MetroNews7h
Morgantown-based start-up launches pediatric sickle cell treatment, hosts Kenyan leader
Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...